SynGen gets FDA approval to market cord blood products

SynGen Inc., a Sacramento medical device startup that develops stem cell harvesting systems, announced today it was granted Food and Drug Administration 510(k) clearance to market its three related products to process cord blood...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.